Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Hypertension. 2018 Jan 2;71(3):444–450. doi: 10.1161/HYPERTENSIONAHA.117.09649

Table 3.

Weighted Distributions of risk factors/potential confounders.

Period Period 1 Period 2 p-value for difference
Patient Visits (N) N=281 N=408
Sum weights=270.4 Sum Weights=414.0
% or Mean (95% CI) % or Mean (95% CI)
Age, years 12.4 (11.9, 12.8) 12.3 (11.8, 12.7) 0.69
Male 60% 61% 0.85
Black race 19% 20% 0.82
Hispanic Ethnicity 15% 15% 0.83
Baseline Income 0.90
 ≤ 36K 42% 41%
 36–75K 29% 29%
 >75K 29% 30%
Baseline maternal education 0.87
 High school 40% 38%
 Some college 28% 29%
 College or more 32% 33%
Glomerular CKD 25% 26% 0.76
Years of CKD
 Non-glomerular 11.4 (10.8, 11.9) 11.2 (10.7, 11.8) 0.76
 Glomerular, HUS 5.7 (0.9, 10.4) 8.8 (6.5, 11.1) 0.20
 Glomerular, non-HUS 6.7 (5.4, 8.0) 5.6 (4.7, 6.5) 0.16
GFR, mL/min/1.73m2 49 (46, 51) 49 (47, 52) 0.59
log2(uP/C) −1.17 (−1.40, −0.94) −1.26 (−1.48, −1.03) 0.59
BMI z 0.43 (0.28, 0.57) 0.40 (0.29, 0.51) 0.75
Growth failure, HT %ile<5 16% 15% 0.67
Low birth weight 19% 19% 0.85
SR-High BP diagnosis 55% 56% 0.85
Current corticosteroid 7% 7% 0.94
Antihypertensive use 68% 63% 0.18